NorthStrive Biosciences Announces Launch of EL-32 Preclinical Study Evaluating Muscle Preservation in GLP-1 Weight Loss Therapy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/8/2026

1. USO
2. TMUS
3. SPY
4. RKLB
5. PENG
6. KRUS
7. MTZ
8. AMZN
9. FCEL
10. KLAR

Go back to NorthStrive Biosciences Announces Launch of EL-32 Preclinical Study Evaluating Muscle Preservation in GLP-1 Weight Loss Therapy
(NASDAQ: ELAB) Delayed: 1.19 --0 (-0%)
Previous Close $1.19    52 Week High $ 
Open $1.19    52 Week Low $ 
Day High $1.19    P/E N/A 
Day Low $1.19    EPS $ 
Volume 101,090